Wave Life Sciences Ltd. Stock

$6.07

2.45%

Nasdaq, Apr 21, 08:46 pm CET

ISIN

SG9999014716

Symbol

WVE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Wave Life Sciences Ltd. Stock price

$5.92

-2.36 28.50% 5Y

Nasdaq, Closing price Thu, Apr 17 2025

+0.08 1.37%

ISIN

SG9999014716

Symbol

WVE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$908.64m
Enterprise Value	$639.83m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	5.91
P/S ratio (TTM) P/S ratio	8.39
P/B ratio (TTM) P/B ratio	4.32
Revenue growth (TTM) Revenue growth	-4.42%
Revenue (TTM) Revenue	$108.30m
EBIT (operating result TTM) EBIT	$-110.40m
Free Cash Flow (TTM) Free Cash Flow	$-152.45m
Cash position	$302.08m
EPS (TTM) EPS	$-0.79
P/E forward	negative
P/S forward	12.95
EV/Sales forward	9.12
Short interest	11.10%

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Get Started for Free Today

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

??

12 Analysts have issued a Wave Life Sciences Ltd. forecast:

11x Buy

92%

More details on Analyst Estimates Including Price Targets

12 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy

92%

Hold

Analyst Estimates with Stock Price Targets

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	108 108	4% 4% 100%
- Direct Costs	8.66 8.66	6% 6% 8%
Gross Profit	100 100	4% 4% 92%
- Selling and Administrative Expenses	42 42	27% 27% 39%
- Research and Development Expense	160 160	23% 23% 147%
EBITDA	-102 -102	73% 73% -94%
- Depreciation and Amortization	8.66 8.66	6% 6% 8%
EBIT (Operating Income) EBIT	-110 -110	62% 62% -102%
Net Profit	-97 -97	68% 68% -90%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Wave Life Sciences Ltd. Stock News

Positive

Seeking Alpha

●

25 days ago

Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531

Wave Life Sciences Ltd. release of multi-dose data from the phase 1b/2a open-label RestorAAtion-2 study, using WVE-006 for AATD-related lung disease, expected in 2025. Positive results were achieved in the phase 2 FORWARD-53 study, using WVE-N531 for the treatment of patients with DMD amenable to exon 53 skipping; an average dystrophin expression of 7.8% was achieved. The Duchenne Muscular Dyst...

Neutral

GlobeNewsWire

●

26 days ago

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

Statistically significant and clinically meaningful improvement of 3.8 seconds in Time-to-Rise vs. natural history with largest effect observed relative to any approved dystrophin restoration therapy at 48 weeks; additional functional benefits observed in other outcome measures including NSAA

Neutral

Seeking Alpha

●

about 2 months ago

Wave Life Sciences Ltd. (WVE) Q4 2024 Earnings Call Transcript

Wave Life Sciences Ltd. (NASDAQ:WVE ) Q4 2024 Earnings Conference Call March 4, 2025 8:30 AM ET Company Participants Kate Rausch - VP, IR & Corporate Affairs Paul Bolno - President & CEO Erik Ingelsson - Chief Scientific Officer Kyle Moran - Chief Financial Officer Conference Call Participants Ron Feiner - JPMorgan Salim Syed - Mizuho Joon Lee - Truist Securities Joe Schwartz - Leerink Partners...

More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office	Singapore
CEO	Paul Bolno
Employees	288
Founded	2012
Website	www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now